EE200300116A - Efektiivne meetod faktori Xa inhibiitori valmistamiseks - Google Patents

Efektiivne meetod faktori Xa inhibiitori valmistamiseks

Info

Publication number
EE200300116A
EE200300116A EEP200300116A EEP200300116A EE200300116A EE 200300116 A EE200300116 A EE 200300116A EE P200300116 A EEP200300116 A EE P200300116A EE P200300116 A EEP200300116 A EE P200300116A EE 200300116 A EE200300116 A EE 200300116A
Authority
EE
Estonia
Prior art keywords
inhibitor
factor
preparation
effective method
effective
Prior art date
Application number
EEP200300116A
Other languages
English (en)
Inventor
Li Hui-Yin
Anzalone Luigi
Jin Fuqiang
J. Meloni David
Sun Jung-Hui
A. Teleha Christopher
Cheng Zhou Jia
E. Smyser Thomas
Original Assignee
Bristol-Myers Squibb Pharma Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Pharma Company filed Critical Bristol-Myers Squibb Pharma Company
Publication of EE200300116A publication Critical patent/EE200300116A/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EEP200300116A 2000-09-22 2001-09-12 Efektiivne meetod faktori Xa inhibiitori valmistamiseks EE200300116A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23462200P 2000-09-22 2000-09-22
PCT/US2001/028406 WO2002024690A2 (en) 2000-09-22 2001-09-12 Efficient process for the preparation of a factor xa inhibitor

Publications (1)

Publication Number Publication Date
EE200300116A true EE200300116A (et) 2005-04-15

Family

ID=22882119

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300116A EE200300116A (et) 2000-09-22 2001-09-12 Efektiivne meetod faktori Xa inhibiitori valmistamiseks

Country Status (23)

Country Link
US (3) US6667332B2 (et)
EP (1) EP1366045A2 (et)
JP (1) JP2004529853A (et)
KR (1) KR20040043089A (et)
CN (1) CN1610679A (et)
AU (1) AU2001292612A1 (et)
BG (1) BG107813A (et)
BR (1) BR0114102A (et)
CA (1) CA2424576A1 (et)
CZ (1) CZ2003835A3 (et)
EE (1) EE200300116A (et)
HR (1) HRP20030316A2 (et)
HU (1) HUP0500133A2 (et)
IL (1) IL155043A0 (et)
IS (1) IS6754A (et)
MX (1) MXPA03002493A (et)
NO (1) NO20031308L (et)
PL (1) PL366027A1 (et)
RU (1) RU2003111464A (et)
SK (1) SK4892003A3 (et)
TW (1) TW593314B (et)
WO (1) WO2002024690A2 (et)
ZA (1) ZA200302971B (et)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339099B1 (en) * 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors
WO2002006218A2 (en) * 2000-07-18 2002-01-24 Bone Care International, Inc. STABILIZED 1α-HYDROXY VITAMIN D
TW200302225A (en) * 2001-12-04 2003-08-01 Bristol Myers Squibb Co Substituted amino methyl factor Xa inhibitors
AU2003270861A1 (en) 2002-10-02 2004-04-23 Bristol-Myers Squibb Company Novel combination of a factor xa inhibitor and clopidogrel
WO2004041710A1 (ja) * 2002-11-06 2004-05-21 Matsushita Electric Industrial Co., Ltd. 変位検出機能を備えたマイクロアクチュエータ、および当該マイクロアクチュエータを備えた可変形ミラー
US7429581B2 (en) * 2002-12-23 2008-09-30 Sanofi-Aventis Deutschland Gmbh Pyrazole-derivatives as factor Xa inhibitors
US20050059719A1 (en) * 2003-09-16 2005-03-17 Badawy Sherif Ibrahim Farag Solid dosage formulation containing a Factor Xa inhibitor and method
SG11201607267SA (en) 2014-03-07 2016-09-29 Biocryst Pharm Inc Human plasma kallikrein inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020357A (en) * 1996-12-23 2000-02-01 Dupont Pharmaceuticals Company Nitrogen containing heteroaromatics as factor Xa inhibitors
ZA985247B (en) * 1997-06-19 1999-12-17 Du Pont Merck Pharma Guanidine mimics as factor Xa inhibitors.
US6339099B1 (en) * 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors

Also Published As

Publication number Publication date
SK4892003A3 (en) 2004-04-06
KR20040043089A (ko) 2004-05-22
NO20031308L (no) 2003-05-07
IS6754A (is) 2003-03-21
CN1610679A (zh) 2005-04-27
PL366027A1 (en) 2005-01-24
MXPA03002493A (es) 2004-09-10
RU2003111464A (ru) 2004-10-27
WO2002024690A8 (en) 2002-08-08
NO20031308D0 (no) 2003-03-21
US6667332B2 (en) 2003-12-23
BR0114102A (pt) 2005-04-19
WO2002024690A3 (en) 2003-09-25
EP1366045A2 (en) 2003-12-03
CZ2003835A3 (cs) 2003-12-17
BG107813A (bg) 2004-01-30
US20030212117A1 (en) 2003-11-13
WO2002024690A2 (en) 2002-03-28
JP2004529853A (ja) 2004-09-30
CA2424576A1 (en) 2002-03-28
US6747158B2 (en) 2004-06-08
HUP0500133A2 (hu) 2005-04-28
TW593314B (en) 2004-06-21
US20020061917A1 (en) 2002-05-23
ZA200302971B (en) 2005-05-09
AU2001292612A1 (en) 2002-04-02
HRP20030316A2 (en) 2005-02-28
IL155043A0 (en) 2003-10-31
US20040198787A1 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
CY2015028I1 (el) Ενας αναστολεας ν-ακυλοσφιγγοσινο γλυκοζυλοτρανσφερασης
AR028253A1 (es) Inhibidores de la glucogeno fosforilasa
NO20003808L (no) Substituerte oksoazaheterosyklylfaktor Xa inhibitorer
PT1224195E (pt) C-aril-glicosidos inibidores de tgls2
CY2007029I1 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
AR027983A1 (es) Novedosos compuestos
DK1272488T3 (da) Tri-aryl-substitueret ethan-PDE4-inhibitorer
FI20000869A (fi) Menetelmä kiinnirullaimen toimintavarmuuden parantamiseksi
PT1299356E (pt) Novos compostos
EE200300116A (et) Efektiivne meetod faktori Xa inhibiitori valmistamiseks
AR028220A1 (es) Novedosos compuestos
ID29755A (id) Senyawa-senyawa organosilikon
NO20030303D0 (no) Kalsilytiske forbindelser
NO20023508D0 (no) Kalsilyttiske forbindelser
TR200100070A3 (tr) Bilesim
ATE305452T1 (de) Faktor xa inhibitor
EE200200447A (et) Meetod tubaka täitevõime parandamiseks
DE60132468D1 (de) Alen-lanosterol zyklase inhibitoren
DE60114796D1 (de) Analgetisch wirksame benzosuberonylpiperidin-verbindungen
SE0004680D0 (sv) New compound
FI4813U1 (fi) Seinäkesäilytin
ITMI20001649A0 (it) Nessuno
SE0004239D0 (sv) New use of an inhibitor
SE0001804D0 (sv) New compounds II
SE0004127D0 (sv) New Method